MPM BIOVENTURES 2018 L.P. 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 4:06 pm Sale | 2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 3,451,303 4.300% | -1,519,596 (-30.57%) | Filing |
| 2023-02-09 4:04 pm Purchase | 2022-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 4,970,899 9.500% | 19,596 (+0.40%) | Filing |
| 2021-02-12 4:24 pm Purchase | 2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN | MPM BIOVENTURES 2018 L.P. | 4,951,303 10.900% | 4,951,303 (New Position) | Filing |